# Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

> **NCT00279734** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 80 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tetanus + pnemococcal vaccines alone
- **DRUG:** Abatacept + vaccines
- **DRUG:** Abatacept + vaccines
- **DRUG:** Abatacept + Vaccines

## Key facts

- **NCT ID:** NCT00279734
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279734, "Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00279734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*